Publication | Open Access

A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients

AsthmaHigh-risk Peanut-allergic PatientsFood AllergyAllergyAllergy MedicineRapid Oral DesensitizationPharmacologyPeanut AllergyOral ImmunotherapyAllergenFood AllergiesPharmacotherapyChildhood Food AllergyMedicinePilot Study